A Win For EyeGate Pharmaceuticals, Inc.
Tue, Jul 27, 2021 at 05:33 PM
EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ) shot up at $3.77, a gain of 20.8%. On Mon, Jul 26, 2021, EYEG:NASDAQ touched a New 2-Week Low of $3.12. The stock appeared on our News Catalysts scanner on Tue, Jul 27, 2021 at 10:55 AM in the 'ACQUISITION' category. From Mon, Jul 12, 2021, the stock recorded 20.00% Up Days and 27.27% Green Days
The share price of the company has been moving sideways in recent weeks.
About EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ)
Eyegate Pharmaceuticals Inc is a clinical-stage specialty pharmaceutical company. The Company is engaged in developing and commercializing products for treating diseases and disorders of the eye.
Top 10 Gainers:
- Oragenics, Inc. (OGEN:NYSEMKT), 34.14%
- SGOCO Group, Ltd. (SGOC:NASDAQ), 29.56%
- GX Acquisition Corp. (GXGX:NASDAQ), 27.18%
- BiondVax Pharmaceuticals Ltd. (BVXV:NASDAQ), 26.94%
- TAL Education Group (TAL:NYSE), 25.23%
- MOGU Inc. (MOGU:NYSE), 23.3%
- EyeGate Pharmaceuticals, Inc. (EYEG:NASDAQ), 20.83%
- IRSA Propiedades Comerciales S.A. (IRCP:NASDAQ), 20.37%
- JZXN (JZXN:NASDAQ), 19.16%
- Iterum Therapeutics plc (ITRM:NASDAQ), 17.53%